Competencies by care stage
Acute support
In-session support while the participant is under the acute effects of the medicine.
200 competencies mapped to this stage.
Looking for something specific? Ask Blossom
Informed consent, decisional capacity, autonomy, and withdrawal rights
Teaches how to obtain and maintain valid informed consent through clear disclosure, comprehension checks, capacity support, voluntariness, non-coercion, and respect for refusal or withdrawal. The competency also covers consent for screening procedures, recordings, collateral contact, rescue interventions, and documentation of the consent process.
4 roles · 59 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreScreening, eligibility, and readiness assessment
Teaches how to assess clinical suitability before psychedelic or ketamine treatment, including medical and psychiatric screening, readiness evaluation, contraindication review, inclusion/exclusion criteria, and ongoing eligibility re-checks before dosing.
8 roles · 52 guidelines · 15 courses · 12 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreAcute psychological response and emergency management during dosing
Cluster covering 35 related competencies for monitoring acute psychological effects, recognising and managing distress, crisis containment, emergency escalation, and rescue-medication coordination during psychedelic dosing sessions.
6 roles · 51 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreAdverse event identification, documentation, and reporting
Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.
4 roles · 46 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 morePreparation and integration support
Cluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.
7 roles · 43 guidelines · 18 courses · 14 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreSuicide and serious psychiatric risk assessment
Teaches structured assessment of suicidal ideation, intent, psychiatric deterioration, and related high-risk presentations. Learners are trained to use appropriate tools, safety planning, emergency contacts, clinician access, and escalation pathways when risk is identified.
6 roles · 41 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 morePost-dose follow-up, safety monitoring, and retention support
Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.
5 roles · 37 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreDischarge readiness, escort safety, and post-session supervision
Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.
4 roles · 30 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreEmergency recognition, escalation, and disposition planning
Teaches recognition of medical or psychiatric emergencies and the steps required to escalate care safely. The competency includes de-escalation, clinical consultation, 911 or emergency department transfer, serious-event escalation, and referral to appropriate higher-level care.
7 roles · 29 guidelines · 3 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreBlinding, allocation concealment, and unblinding control
Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.
6 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+4 moreMedication, substance-use, washout, and taper management
Teaches review and management of concomitant medications, restricted therapies, prohibited substances, washout periods, tapering requirements, and abstinence expectations. The competency includes participant counseling, medication reconciliation, sponsor notification, and team coordination when restrictions affect safety or interpretability.
5 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreStudy documentation, data integrity, and regulatory recordkeeping
Teaches accurate study documentation, source-record quality, secure data capture, Good Clinical Practice recordkeeping, IRB and sponsor documentation requirements, monitoring readiness, audit support, accountability, and retention obligations.
3 roles · 27 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreManualized psychedelic psychotherapy delivery
Teaches delivery of psychedelic-assisted psychotherapy according to an approved study manual across preparation, dosing, integration, and follow-up. The competency balances standardized structure with non-directive support for the participant’s therapeutic process.
4 roles · 25 guidelines · 3 courses · 2 providers
KetamineLSDMDMA+1 moreTherapeutic boundaries, professional conduct, and consent for touch
Teaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.
7 roles · 24 guidelines · 4 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreCo-therapist and multidisciplinary team coordination
Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.
4 roles · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreStudy record and trial registration literacy
Teaches how to understand ClinicalTrials.gov records and related study information, including glossary terms, registration fields, protocol descriptors, and results-reporting elements used to interpret clinical research records.
3 roles · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 morePhysical safety monitoring
Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.
5 roles · 19 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreAcute psychiatric and behavioral risk monitoring
Teaches continuous monitoring for distress, confusion, psychotic symptoms, suicidality, agitation, and other acute behavioral risks during and after dosing. The focus is early recognition, documentation, and escalation to clinical support when risk emerges.
5 roles · 17 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 morePreparation support
Cluster covering 11 related competencies including: Preparation support, Psilocybin preparation, Therapeutic preparation.
3 roles · 16 guidelines · 6 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreSupportive nondirective therapeutic stance
Cluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.
2 roles · 16 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 morePsilocybin session facilitation
Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.
6 roles · 14 guidelines · 6 courses · 5 providers
LSDPsilocybinAdverse effects and side-effect management
Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.
6 roles · 14 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineKetamine+3 morePsychedelic-assisted psychotherapy preparation and integration
Teaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.
6 roles · 13 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreHallucinogen pharmacology and effects
Cluster covering 7 related competencies including: Physiologic safety awareness, Hallucinogen pharmacology and effects, Hallucinogen-assisted therapy knowledge.
4 roles · 13 guidelines · 0 courses · 0 providers
LSDPsilocybinKetamine psychotherapy delivery
Cluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.
6 roles · 12 guidelines · 7 courses · 5 providers
KetamineDissociation and acute neuropsychiatric effect monitoring
Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.
5 roles · 12 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+1 morePhysiologic monitoring, thermoregulation, hydration, and overdose response
Teaches monitoring and response for acute physiological risks, including vital signs, temperature, hydration, overheating, excessive fluid intake, and suspected overdose. The competency emphasizes supportive care, medical coordination, documentation, and escalation when needed.
6 roles · 11 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreSpecial-interest adverse event vigilance
The protocol requires active monitoring for psychedelic-specific adverse events such as hallucinations, psychotic symptoms, dissociation, mood alteration, and cognitive disturbance. These require immediate notification and follow-up.
3 roles · 11 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreDepression symptom and remission monitoring
Teaches structured monitoring of depressive symptoms, response, and remission across treatment and follow-up. Learners use standardized scales and clinical review to track change and identify deterioration or non-response.
2 roles · 10 guidelines · 0 courses · 0 providers
IbogaineKetamineLSD+1 moreMindfulness, intention-setting, set and setting, and somatic presence
Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.
6 roles · 9 guidelines · 7 courses · 6 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreTrauma-informed therapeutic presence and somatic support
Teaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.
2 roles · 9 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinGrounding and regulation techniques
Therapists must be able to teach and coach grounding practices that help participants regulate during preparation and dosing. These methods are used before medication and during distress.
2 roles · 9 guidelines · 0 courses · 0 providers
MDMAPsilocybinOutcome Measure and Assessment Literacy
Teaches clinicians and research staff to understand the purpose, limits, scoring, interpretation, and clinical meaning of psychological measures and study instruments used to evaluate symptoms, functioning, safety, and treatment outcomes.
3 roles · 9 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreClient preparation and therapeutic set/setting
Cluster covering 2 related competencies including: Preparation of set and setting, Client preparation and therapeutic set/setting.
3 roles · 8 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetamineLSD+2 morePhysiologic monitoring during ketamine administration
Cluster covering 2 related competencies including: Safety monitoring during ketamine dosing, Physiologic monitoring during ketamine administration.
4 roles · 8 guidelines · 0 courses · 0 providers
KetaminePsychedelic-assisted therapy facilitation
Cluster covering 2 related competencies including: Psychedelic-assisted therapy facilitation, Group facilitation in a psychedelic setting.
3 roles · 8 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineLSD+2 morePsychological support during altered states
Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.
3 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreTraining and competency maintenance
Therapists and study personnel are expected to receive structured training and ongoing supervision. Competence includes both protocol adherence and the ability to work safely and consistently across sites.
3 roles · 8 guidelines · 0 courses · 0 providers
MDMAPsilocybinUse outcome assessment and follow-up to evaluate response
The study used standardized anxiety measures and followed patients for 2 months and 12 months, implying competence in tracking outcomes over time. Therapists should be able to assess symptom change and sustained benefit using structured follow-up.
2 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreVital sign and physical distress monitoring
Monitors participant physical status during study visits and identifies concerning changes requiring escalation. Vital signs and symptomatic changes are part of routine safety observation.
4 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreCultural humility, Indigenous respect, and equity-oriented care
Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.
6 roles · 7 guidelines · 11 courses · 10 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreTransference, countertransference, and therapist self-awareness
Teaches recognition and management of relational dynamics that can intensify in psychedelic-assisted therapy. Learners develop self-awareness around countertransference, projection, attachment, dependency, and other therapeutic-process risks.
3 roles · 7 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineMDMA+1 moreClinical interviewing and history-taking
Therapists and study clinicians perform detailed biopsychosocial interviewing during preparation and screening. This supports treatment planning, risk assessment, and therapeutic understanding.
2 roles · 7 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinMedical escalation and rescue medication coordination
Cluster covering 2 related competencies including: Medical escalation and rescue medication use, Medical escalation and rescue medication coordination.
4 roles · 7 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinSafe Therapeutic Container Creation
Teaches providers to create and maintain a psychologically and physically safe therapeutic setting through clear structure, preparation, boundaries, attunement, environmental design, and ongoing attention to participant safety.
4 roles · 6 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreCultural and spiritual sensitivity
Responds respectfully to spiritual, mystical, and value-related themes that may arise during psilocybin sessions and debriefing. Integrates these themes into therapy without imposing interpretations.
2 roles · 6 guidelines · 0 courses · 0 providers
IbogaineMDMAPsilocybinIntegration and post-session debriefing
Cluster covering 4 related competencies including: Integration and debriefing, Integration and debriefing facilitation, Integration and post-session debriefing.
2 roles · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinKetamine infusion monitoring
Cluster covering 5 related competencies including: Cardiac safety monitoring, Ketamine infusion monitoring, Ketamine infusion administration.
3 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreMedication taper and withdrawal monitoring
Teaches monitoring during down-titration or discontinuation of psychiatric medications before dosing. Learners track withdrawal symptoms, symptom worsening, suicidality, and other risks that may emerge during tapering.
4 roles · 6 guidelines · 0 courses · 0 providers
IbogainePsilocybinSafe treatment-setting facilitation
Provide a calm and supportive environment during treatment to reduce distress and support tolerance of the experience. The case report notes food, rest, and a quiet place as part of care.
2 roles · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMescalineTherapeutic rapport building
Cluster covering 4 related competencies including: Therapeutic rapport building, Rapport building and trust development, Therapeutic rapport and trust building.
2 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDPsilocybinPsilocybin psychotherapy framework
Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.
6 roles · 5 guidelines · 4 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinEthical psychedelic facilitation
Cluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.
7 roles · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTIbogaineKetamine+1 moreSession facilitation and therapeutic holding
Cluster covering 2 related competencies including: Session facilitation and therapeutic holding, Session facilitation and support during intense experiences.
3 roles · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreManagement of concomitant medication interactions
Cluster covering 5 related competencies including: Concomitant medication review, Contraindication and interaction awareness, Contraindications, drug effects, and interactions.
4 roles · 5 guidelines · 1 courses · 1 providers
IbogaineLSDPsilocybinAssessment administration and interpretation
Ability to administer and interpret structured interviews, clinician ratings, and self-report measures used in the study. Therapists contribute to eligibility, safety, and outcome assessment.
2 roles · 5 guidelines · 0 courses · 0 providers
LSDPsilocybinEvaluate clinically significant response and treatment outcomes
Therapists/facilitators should be able to judge whether therapeutic change reaches clinically meaningful thresholds, not just whether symptoms improve numerically. This supports informed ongoing care and communication about benefits and limitations.
2 roles · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTKetamineLSD+2 moreFacilitate processing of difficult emotions
Therapists must help patients face and work through grief, fear, rage, panic, shame, guilt, and existential distress rather than avoid them. The clinician supports emotional expression while maintaining safety and meaning-making.
2 roles · 5 guidelines · 0 courses · 0 providers
MDMAPsilocybinMatch dose and setting to patient capacity
Therapists/facilitators need judgment about dosing and setting so experiences remain tolerable and therapeutically useful. The paper repeatedly notes that when dose and setting are appropriate, emerging material remains within the patient’s capacity to cope.
2 roles · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSD+2 moreParticipant safety planning and support network coordination
Can identify and involve support persons, attendants, and outside providers to enhance safety. The facilitator must coordinate practical supports while respecting confidentiality and protocol boundaries.
3 roles · 5 guidelines · 0 courses · 0 providers
MDMAPsilocybinProvide overnight and next-day containment
Therapists must ensure continuity of care after the acute session, including overnight observation and next-morning integration before discharge. This reflects a containment and recovery responsibility beyond the dosing period.
3 roles · 5 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+2 moreResearch assessment administration
Administer study measures and structured assessments on schedule, including psychological, spiritual, and neurobehavioral instruments. This includes both paper-based and Storyline-based assessments.
2 roles · 5 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinRespect autonomy and individualized communication preferences
Adapt language and interpersonal style to the patient’s preferences to promote dignity and comfort. The therapist should also respect the patient’s autonomy within safety limits.
2 roles · 5 guidelines · 0 courses · 0 providers
IbogaineKetamineMDMA+1 moreRisk screening and exclusion judgment
Know the medical and psychiatric exclusions that protect participants from foreseeable harm. Facilitators must recognize conditions that make MDMA-assisted psychotherapy unsafe or inappropriate.
3 roles · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreTrauma-focused exposure facilitation
Facilitate trauma exposure in a structured, supportive, and protocol-consistent manner. The therapist must be able to initiate, pace, and process exposure work while maintaining adherence to PE methods.
2 roles · 5 guidelines · 0 courses · 0 providers
KetamineMDMAUnderstand dose-response and time course
The facilitator should know how oral and intravenous dosing relate to onset, duration, and peak effects. This knowledge supports proper session planning, monitoring, and integration timing.
2 roles · 5 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSD+3 moreProfessional self-care and burnout prevention
Teaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.
5 roles · 4 guidelines · 3 courses · 3 providers
KetamineMDMAPsilocybinRisk evaluation and safety monitoring
Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.
6 roles · 4 guidelines · 3 courses · 2 providers
5-MeO-DMTIbogaineKetamine+2 moreMusic and therapist-variable awareness
The course explicitly mentions the role of music and therapist variables in treatment. Learners are expected to understand how these elements influence the PAP experience and therapeutic outcome.
3 roles · 4 guidelines · 1 courses · 1 providers
KetamineMDMATherapeutic touch judgment
The training includes appropriate use of therapeutic touch as part of safe delivery. Learners are expected to use touch judiciously and within ethical boundaries.
4 roles · 4 guidelines · 1 courses · 1 providers
MDMAWorking with inner healing intelligence
The course teaches how to work with the 'Inner Healing Intelligence,' indicating a non-directive or facilitative stance toward client-led healing processes. This is framed as a core therapeutic concept in psychedelic work.
3 roles · 4 guidelines · 1 courses · 1 providers
MDMAFacilitate integration of experience into behavioral change
Cluster covering 2 related competencies including: Integration of psychedelic experience with behavior change, Facilitate integration of experience into behavioral change.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinIndependent outcome assessment administration
The facilitator must administer and coordinate patient-rated and clinician-rated measures while minimizing bias. Assessments should be completed independently and in the correct order.
3 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+1 moreManage agitation and elopement risk
Respond to agitation or attempts to leave the room in a way that preserves safety for the patient and others. The therapist should use containment, redirection, and escalation protocols when needed.
3 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMDMA+1 moreManagement of residual symptoms and re-entry
Therapists must prepare the subject for residual effects after the main session and provide practical safeguards for sleep, transportation, and home support. This includes framing recurrence of symptoms in a non-alarming way.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMescalineMonitor acute and short-term adverse effects
The study emphasizes the absence of acute or chronic adverse effects persisting beyond 1 day and no treatment-related serious adverse events, indicating the need for active monitoring during and after treatment. Facilitators must be able to observe, document, and respond to adverse reactions.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreNonintrusive session monitoring and containment
Facilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.
2 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMA+1 morePsilocybin psychoeducation
Cluster covering 2 related competencies including: Psilocybin psychoeducation, Psychedelic psychoeducation and expectation management.
2 roles · 4 guidelines · 0 courses · 0 providers
MDMAPsilocybinStructured symptom rating administration
Facilitators must competently administer and interpret clinician-rated ADHD and global severity measures. Accurate scoring is essential because these scales determine eligibility and outcomes.
3 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSDCrisis and adverse-event response
The page signals training in managing difficult or high-risk moments, including crisis intervention and trigger management. Learners are expected to respond appropriately when a session becomes destabilizing or unsafe.
6 roles · 3 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreSafety monitoring and emergency awareness
The page points to checklists and a guide to basic medical emergencies, indicating that learners should be able to monitor safety and recognize urgent issues. The overall training context also stresses keeping both client and practitioner safe.
5 roles · 3 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineMDMABalance inner focus with communication
Therapists should support an appropriate rhythm between inward experiential focus and verbal interaction, with either therapist or participant able to initiate shifts.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMAExpectation and expectancy management
Understand how treatment expectations can influence treatment response and study interpretation. Facilitation must avoid inadvertently shaping expectations in a biased or misleading way.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaFacilitating insight and peak experiences
The protocol assumes therapeutic value in insight, catharsis, and peak experiences, so the therapist must support conditions that may allow these to emerge safely and meaningfully. This includes recognizing and working with symbolic and transformative material.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineKetamineInformed consent responsibility
Facilitators are responsible for ensuring that participants have provided informed consent before receiving MDMA-assisted therapy. This reflects an ethical and regulatory duty central to work with investigational treatments.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMAKnowledge of MDMA effects and risks
Facilitators must understand the expected psychological, physiological, and potential adverse effects of MDMA in order to prepare participants, support the session, and detect complications.
3 roles · 3 guidelines · 0 courses · 0 providers
MDMAMindfulness instruction
Facilitator can teach and cue mindfulness practices consistent with the study protocol. Mindfulness is presented as present-moment, nonjudgmental awareness.
2 roles · 3 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinNo extractable therapist/facilitator competencies in provided source text
The provided source text is only a ClinicalTrials.gov interface/header snippet and does not contain study intervention procedures, therapist qualifications, facilitator responsibilities, safety monitoring procedures, or ethical guidance specific to clinical practice.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTKetamineOpioid withdrawal assessment
Evaluates opioid withdrawal symptoms and tracks changes over time in participants discontinuing methadone OST. Uses standardized withdrawal ratings to assess potential treatment effects and safety.
2 roles · 3 guidelines · 0 courses · 0 providers
IbogainePsychoeducation about MDMA effects and session trajectory
Therapists must understand MDMA’s expected subjective, interpersonal, and physiological effects and prepare participants accordingly. This knowledge supports normalization, reassurance, and effective use of the medicine within therapy.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMAPsychological preparation and anxiety reduction
Facilitators need practical skills in preparing participants emotionally for ketamine administration and reducing distress. The protocol highlights relaxation, breathing, and grounding strategies to reduce anxiety or discomfort associated with the drug experience.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetaminePsychological state assessment
Administer and interpret psychological and psychometric measures relevant to mood, cravings, expectations, mystical experience, ego dissolution, and functioning. Facilitators must accurately support questionnaire-based assessment across time points.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDMescaline+1 moreSetting optimization
Create an environment that supports safety, comfort, and relaxation during the session. The setting is deliberately structured to reduce anxiety and facilitate a positive experience.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaineSupport safe administration of LSD dosing sessions
Because the protocol involved specific LSD doses, active placebo control, and session spacing, facilitators need applied skill in implementing dosing-session procedures safely and consistently. This includes maintaining therapeutic support while adhering to protocol constraints.
2 roles · 3 guidelines · 0 courses · 0 providers
LSDMescalineTeach and apply stress inoculation and anxiety support
Therapists should identify or teach in-session coping tools and collaboratively plan how anxiety states will be recognized and supported.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAPsilocybinTherapeutic alliance and trust building
The therapist must create an atmosphere of confidence and mutual understanding before ketamine administration. This relationship is treated as a key therapeutic factor in the protocol.
1 role · 3 guidelines · 0 courses · 0 providers
IbogaineKetaminePsilocybinTherapeutic rapport and engagement support
Help patients engage in emotionally intense trauma-focused treatment and reduce dropout risk. The therapist should recognize comorbid depression or anxiety that may interfere with adherence and response.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMAHarm reduction and risk awareness
Cluster covering 5 related competencies including: Harm-reduction orientation, Harm reduction and risk awareness, Harm reduction for client support.
7 roles · 2 guidelines · 5 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreDosing-day facilitation
Cluster covering 2 related competencies including: Dosing-day facilitation, Dosing-session facilitation.
4 roles · 2 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinLegal and Regulatory Navigation
Teaches practitioners to identify and apply relevant legal, regulatory, ethical, and institutional requirements, including documentation, consent, reporting, controlled-substance, and jurisdiction-specific obligations.
6 roles · 2 guidelines · 2 courses · 2 providers
IbogaineKetamineMDMA+1 moreBasic life support
Learners are explicitly offered Basic Life Support training, indicating emergency readiness and medical safety preparation. The page notes DORA-required status, signaling regulatory safety relevance.
5 roles · 2 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineGuided inquiry and reflective language
Students learn to use language and questions that deepen a client’s inner experience and support healing. This is a practical communication competency for facilitation and integration work.
2 roles · 2 guidelines · 1 courses · 1 providers
LSDMDMAPsilocybinTherapist self-regulation
The curriculum explicitly includes therapist self-regulation as a therapeutic skill. This suggests learners are expected to maintain steadiness and presence while supporting clients in altered states.
4 roles · 2 guidelines · 1 courses · 1 providers
MDMAPsilocybinBaseline history taking
Collect and interpret baseline behavioral, psychiatric, and medical history relevant to psilocybin research. This information is used to determine eligibility and contextualize outcomes.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinDeliver mindfulness and grounding exercises
Use brief mindfulness practices and grounding strategies to stabilize attention and reduce distress before and during the session. These techniques help the patient reconnect to present-moment awareness and bodily sensation.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinMaintain beginner’s mind
Therapists should cultivate openness about both the participant’s process and their own interpretations. This prevents forcing experience into rigid theoretical frames and supports curiosity and compassion.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAMeaning-making support
Help patients develop coherent, values-consistent meaning from difficult experiences and MDMA session material. Meaning-making is treated as a core ingredient of recovery and post-traumatic growth.
1 role · 2 guidelines · 0 courses · 0 providers
IbogaineMDMAMotivational enhancement for quitting
Elicit and strengthen motivation to quit smoking and remain abstinent. Facilitators use sessions to explore values, reasons for quitting, and treatment commitment.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinOutcome and safety measure literacy
Knowledge of the trial’s primary, secondary, and exploratory endpoints and the instruments used to assess them. This enables accurate administration and interpretation of study procedures.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetaminePatient monitoring during ibogaine administration
Monitors patients closely during treatment because serious adverse outcomes may occur. Safety monitoring is essential given that one participant died during treatment in the study.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogainePeak experience assessment
Ability to assess whether the target acute psychedelic experience has occurred using the study-defined scale and threshold. This was used to guide individualized dosing.
2 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTPreparation for altered-state experience
A major therapist competency is preparing patients extensively for the ketamine session, including the nature of the special state of consciousness and possible ego dissolution or separation from the body. Preparation is both educational and psychotherapeutic.
1 role · 2 guidelines · 0 courses · 0 providers
KetamineMDMAPsychedelic phenomenology literacy
Understand the characteristic acute experiential domains elicited by ayahuasca. This includes perceptual, somatic, cognitive, affective, mystical, and temporal-spatial alterations.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaRespiratory monitoring
Facilitators must watch for slowed breathing, sleep apnea-related hypoxia, disordered breathing, and oxygen desaturation. Oxygenation needs ongoing assessment during the acute and post-acute periods.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineSafety monitoring for adverse effects
Monitors for potential adverse effects associated with ibogaine administration and the detoxification period, even though the abstract primarily reports outcomes rather than specific events.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineStress inoculation and breathwork instruction
At least one therapist must be able to teach stress inoculation methods, especially diaphragmatic breathing, and apply breath-based interventions during sessions. Breath is used both for relaxation and for staying present with difficult experience.
2 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMATraining in PAP and protocol manual adherence
Therapists must be specifically trained in psilocybin-assisted psychotherapy and in the study’s manualized procedures. Competence includes familiarity with the therapeutic model and difficult-state management guidance.
2 roles · 2 guidelines · 0 courses · 0 providers
PsilocybinUnderstanding MDMA effects and non-linear healing
Therapists must have a thorough understanding of MDMA’s subjective, relational, and physiological effects, including the non-linear way these may support healing. This knowledge is necessary for preparation, in-session decisions, and normalization of participant experiences.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAWithdrawal symptom assessment
Measure opioid withdrawal severity using standardized instruments and interpret symptom severity over time. Facilitators must be able to collect both objective observation and patient-reported data.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineWork with bodily sensations and somatic process
Therapists should orient to and explore the participant’s somatic experience, both in experimental and integrative sessions, as a central channel of processing.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAPsychedelic research literacy and evidence appraisal
Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.
7 roles · 1 guidelines · 11 courses · 8 providers
IbogaineKetamineLSD+2 moreTrauma-informed care
Cluster covering 2 related competencies including: Trauma-informed care, Trauma-informed psychedelic care.
4 roles · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinProfessional Scope and Practice Alignment
Teaches clinicians to recognise their role boundaries, align services with training, licensure, supervision, and organisational policy, and refer or escalate when participant needs fall outside their scope of competence.
6 roles · 1 guidelines · 3 courses · 2 providers
IbogaineMDMAPsilocybinPsychedelic integration support
Cluster covering 2 related competencies including: Psychedelic integration support, Psychedelic knowledge integration.
4 roles · 1 guidelines · 2 courses · 2 providers
DMT / AyahuascaPsychotherapeutic facilitation methods
Cluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.
4 roles · 1 guidelines · 2 courses · 2 providers
LSDPsilocybinTrauma-informed practice
Cluster covering 2 related competencies including: Trauma-informed practice, Trauma-informed clinical practice.
2 roles · 1 guidelines · 2 courses · 1 providers
MDMAPsilocybinConfidentiality and trust maintenance
The course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.
4 roles · 1 guidelines · 1 courses · 1 providers
LSDAcute monitoring of subjective intensity
Track the participant’s subjective drug intensity during the active phase of the session. This includes recognizing when the participant cannot respond and how to document maximum intensity.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaAftercare planning
Develop follow-up care after the acute ibogaine period to support behavior change and relapse prevention. The manual emphasizes that the treatment session alone is not enough for long-term recovery.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineAlcohol withdrawal risk management
Clinicians must recognize the life-threatening nature of alcohol withdrawal and ensure adequate detoxification before treatment. Postponement and medical supervision are required when withdrawal risk is present.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineAwareness of ibogaine pharmacology and effects
Understand the proposed mechanisms, phases of effect, and common subjective and physical effects of ibogaine relevant to clinical supervision. This knowledge informs safe monitoring and therapeutic pacing.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineBenzodiazepine-support management
Use supportive anxiolytic or hypnotic medication only when allowed and clinically indicated. This requires careful judgment to balance comfort, safety, and preservation of the session’s integrity.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaBoundary-respecting physical support
Use physical contact only when necessary, explicitly permitted, and minimal. The facilitator must respect participant autonomy and avoid any contact that is not justified for safety or grounding.
1 role · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaCheck-in and timing of interventions during sessions
Therapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAClinical experience for assistant facilitator
Assistant facilitators require practical clinical experience in a licensed healthcare setting. Their role supports safety, containment, and session logistics rather than independent psychotherapy practice.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineClinician therapist availability and scope
At least one therapist in the dyad must be a clinician with capability to assess and manage medical or psychiatric adverse events during the dosing session. This reflects a required competency boundary between general support and clinical responsibility.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinCollaboration with medical and nursing staff
Ketamine-assisted treatment in this protocol is multidisciplinary, so facilitators must work closely with study doctors and nurses. This includes coordinating preparation, understanding monitoring responsibilities, and escalating concerns appropriately.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineCollaborative choice-making
Work collaboratively with the patient, sharing observations and options while preserving the patient’s authority over their process. This supports empowerment in the context of trauma-related loss of control.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAContextualization and ceremony design
Facilitators may use ritual, music, prayer, altar work, or minimalist approaches to frame the experience. Whatever the style, they should use contextualization intentionally and in service of the participant’s process.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTCultural awareness and inclusion
The training framework explicitly includes cultural awareness and inclusion, and examples identify culturally insensitive behavior as clinically inappropriate.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMADrug interaction and mechanism awareness
Understand the role of serotonergic mechanisms and the implications of receptor antagonism for acute psychedelic effects. Use this knowledge to interpret responses and co-administration effects.
2 roles · 1 guidelines · 0 courses · 0 providers
MescalineFacilitate post-session reflection and home practices
Therapists should guide participants toward practices that support reflection, grounding, and continuing integration between visits. These activities extend the therapeutic process beyond formal sessions.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAFocused bodywork competence
Focused bodywork is an optional advanced intervention used to facilitate release of blocked emotion or somatic tension when spontaneous processing has stalled. Therapists need specific judgment and skill to apply it safely and only when indicated.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAHelp patients generalize new coping responses
Therapists must teach patients to reactivate the acceptance, reduced fear, and interpersonal openness experienced during MDMA sessions when confronting later stressors. This helps convert acute session experiences into durable coping skills.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAIn-session emotional support
During ketamine administration, the therapist provides continuous emotional support while the patient reclines with eyeshades and music. This support helps the patient tolerate and make use of the psychedelic experience.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineIntegrated pain-psychiatric care
Works with the combined clinical picture of chronic pain, depression, anxiety, and PTSD symptoms. Provides psychotherapy that is responsive to both somatic and psychiatric suffering.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineKnowledge of therapeutic mechanism and expected time course
The therapist/facilitator should know the expected onset, peak, and persistence of effects to guide monitoring and interpretation. The source reports acute effects with follow-up improvements lasting days.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaMaintain a post-session safety net
Therapists must provide continuity, availability, and clear support structures after MDMA sessions to reduce anxiety and manage emerging difficulties. This safety net extends beyond the dosing day.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAManagement of acute confusional state
Providers must be able to recognize and safely manage acute confusional states, which may look like a psychological break from reality. The emphasis is on physical safety, constant supervision, and avoiding abrupt antipsychotic intervention.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineMedical contraindication screening
Recognizes medical factors that may increase risk during inhaled 5-MeO-DMT administration. Medical clearance is required before dosing.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / Ayahuasca5-MeO-DMTMedical symptom monitoring and selective testing
Therapists/facilitators must monitor for adverse medical signs during sessions and obtain targeted testing when clinically indicated. Safety practice should balance participant comfort with symptom-triggered medical evaluation.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAMusic selection and management
Use music intentionally as part of the therapeutic environment and processing sequence. Music should support, not direct, the patient’s unfolding internal experience.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAOn-site physician emergency competence
A study physician with psychiatric and cardiovascular emergency expertise must be available during dosing. This reflects a requirement for advanced emergency readiness and clinical judgment.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineOngoing informed consent
Treat consent as a continuing process rather than a one-time event. Patients must understand the treatment and retain the ability to revoke consent, with special procedures during the medication session for safety.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAOnset-phase reassurance and symptom redirection
During onset, therapists must help the subject stay relaxed, accept changes, and avoid fixation on somatic discomfort or irrelevant ideation. Music and reassurance are highlighted as practical tools for reducing fear and helping the subject welcome altered perception.
2 roles · 1 guidelines · 0 courses · 0 providers
LSDPossess relevant clinical training and experiential understanding
Therapists should have standard training in psychotherapy for anxiety associated with medical illness and would benefit substantially from personal familiarity with non-ordinary states of consciousness. Such understanding improves empathy, confidence, and process navigation.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAPre-onset psychological set management
Before symptoms begin, the therapist must prevent boredom, over-monitoring for effects, and escalating apprehension. This phase is treated as crucial because the psychological set established here shapes much of what follows.
1 role · 1 guidelines · 0 courses · 0 providers
LSDPsychedelic pharmacology and interaction awareness
Understand the pharmacology and interaction risks of 5-MeO-DMT/BPL-003, including serotonergic and cardiovascular concerns. This knowledge informs safe preparation, exclusion screening, and monitoring.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / Ayahuasca5-MeO-DMTPsychiatric assessment using structured interviews
Conduct or support psychiatric screening using clinical interviews and structured diagnostic tools. The goal is to establish baseline mental health status and detect exclusionary disorders or instability.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinPsychological support during integration
Therapists should support evaluation, emotional processing, and integration after the acute experience. This includes helping patients reflect without over-directing or interrupting the process.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineRecognition of contextual limitations
The facilitator should understand that effects observed in a controlled clinical setting may differ from those in ceremonial or ritual contexts. This awareness shapes interpretation and informs safer translation to other settings.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaShort-duration session management
The facilitator should be able to manage a brief but intense treatment window. The source suggests a shorter-acting psychedelic may enable rapid onset of response and reduce burden compared with longer-acting agents.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSubstance composition and batch awareness
Know that ayahuasca composition can vary and that chemical characterization matters. Facilitators or clinical teams should understand the potency and stability of the administered brew.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaSUDS-guided exposure monitoring
Use Subjective Units of Distress Scale ratings to track fear activation and extinction during PE sessions. This requires eliciting reliable distress ratings and using them to guide exposure processing.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineSupport for spontaneous somatic expression
Participants may express the medicine through shaking, curling, dancing, screaming, glossolalia, orgasm, or other intense bodily responses. The facilitator should recognize these as possible natural responses and support them appropriately.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSupportive context design
The article indicates that a structured, supportive context is associated with more positive acute and enduring effects and fewer challenging experiences. Facilitators should actively design the session context around safety and support.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTTherapeutic use of equipment and stimuli
The handbook describes skillful use of music, images, mirrors, and simple comforts to guide attention, reduce distress, and deepen self-examination. These supports are not incidental but part of the structured method.
1 role · 1 guidelines · 0 courses · 0 providers
LSDTiming and calibration of interventions
A key applied skill is knowing when to remain silently present, when to inquire, and when to offer more active guidance. Effective work depends on moment-to-moment attunement to verbal, nonverbal, historical, and pharmacological cues.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMATreat all emergent material as therapeutically relevant
Therapists should respond as though whatever arises in session—pleasant, difficult, peripheral, symbolic, or practical—may have relevance to healing.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAUse of music, chant, sound, and aroma
Facilitators may use sound and scent intentionally to support launch, peak, and re-entry, but these modalities must never become distracting. They need judgment about timing, dosage, and participant responsiveness.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTUse of observation and assessment tools
The therapist should assess both the immediate experience and longer-term change, using structured observation, self-report, and reports from others where possible. The handbook treats evaluation as difficult but necessary for understanding therapeutic effects.
1 role · 1 guidelines · 0 courses · 0 providers
LSDUse self-directed enquiry
Help participants direct attention to their own present-moment internal experience and explore it from multiple perspectives. This is practiced in preparation and used to support participants if challenging material emerges during dosing.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinVital sign and clinical observation awareness
Understand the expected acute physiological effects of BPL-003 and monitor for clinically meaningful changes. The facilitator should recognize that transient blood pressure and heart rate increases may occur.
1 role · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTWithdrawal symptom management
Support patients through acute opioid withdrawal during ibogaine treatment when withdrawal symptoms are present. The source describes use of oral hydromorphone for symptom relief within the protocol.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineCase-based practice, peer consultation, and professional learning community
Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.
7 roles · 0 guidelines · 8 courses · 7 providers
KetaminePsilocybinNeurobiology of non-ordinary states
Teaches the neurobiological basis of psychedelic and non-ordinary states, including default mode, salience, fear, and related brain-network models. The competency links altered-state phenomenology with therapeutic mechanisms and clinical implications.
4 roles · 0 guidelines · 4 courses · 4 providers
KetaminePsilocybinEthics and ethical practice
Cluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.
6 roles · 0 guidelines · 4 courses · 3 providers
MDMAPsilocybinPreparation and therapeutic alliance
Cluster covering 2 related competencies including: Preparation and therapeutic alliance, Preparation and therapeutic alliance building.
3 roles · 0 guidelines · 2 courses · 2 providers
Dosing-session framework
Cluster covering 2 related competencies including: Dosing-session framework, Dosing-session framework use.
4 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinLegal access pathways and care-team coordination
Teaches how participants move through lawful access routes and coordinated care pathways. The competency covers referral navigation, team handoffs, and the practical steps needed to connect eligible participants with appropriate treatment or study settings.
6 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinActive guiding and purposeful intervention
The course also teaches a more active guiding style, especially through Ralph Metzner’s approach, where guides may introduce focused inquiries, somatic practices, or other interventions. Learners are shown how interventions can shape the trajectory of a session when used skillfully.
3 roles · 0 guidelines · 1 courses · 1 providers
Apprenticeship and mentor shadowing
The program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinClinical trial training and feedback use
The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.
6 roles · 0 guidelines · 1 courses · 1 providers
Debriefing and reflective practice
The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.
5 roles · 0 guidelines · 1 courses · 1 providers
Ethical grounding and integrity
The course repeatedly emphasizes ethical considerations, safety, and integrity in practice. Learners are expected to develop a grounded professional stance that respects legal boundaries and participant welfare.
6 roles · 0 guidelines · 1 courses · 1 providers
Expanded-state therapeutic skills
The course explicitly teaches techniques for working with patients in altered states, including grounding, breathwork, and mindfulness. These are presented as tools for supporting expanded and ordinary states of consciousness.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineLeadership and coaching presence in expanded states
Faculty and program structure emphasize leadership, coaching presence, and personal transformation as part of practitioner development. Students are expected to become more skillful in guiding high-achieving and growth-oriented clients.
3 roles · 0 guidelines · 1 courses · 1 providers
Observing and holding space without reacting
Learners are expected to develop the ability to witness clients and processes calmly, without overreacting or trying to control the experience. The course explicitly frames this as foundational to practitioner development.
4 roles · 0 guidelines · 1 courses · 1 providers
Respond ethically and relationally in crisis
The course explicitly includes ethical and relational considerations in crisis response. This suggests learners are trained to act with care, boundaries, and attunement when responding to acute distress.
4 roles · 0 guidelines · 1 courses · 1 providers
Ritual closing and cleansing
The training includes practices for cleansing and closing psychedelic sessions appropriately. This signals competence in ending sessions in a structured, culturally responsive way.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineSafety, ethics, and responsibility in expanded states work
The course explicitly states that facilitators are guided in safety, ethics, and responsibility. Learners are expected to recognize and manage the unique risks of working with altered states.
3 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSpace preparation and ceremonial setup
Practicum hours may include operational tasks like preparing rooms, setting up altars, and arranging ceremonial spaces. These are treated as part of hands-on professional competence.
4 roles · 0 guidelines · 1 courses · 1 providers
Structured PAP process navigation
The course teaches the overall PAP workflow from screening through follow-up. Learners are expected to understand and explain each phase of treatment in a structured way.
4 roles · 0 guidelines · 1 courses · 1 providers
KetamineSupervised experiential practice
A defining feature of the training is hands-on experiential practice in both non-substance and substance-based modalities under supervision. Learners practice patient and therapist roles, facilitating and undergoing sessions in a structured learning context.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSupervised practicum and feedback integration
Students complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.
4 roles · 0 guidelines · 1 courses · 1 providers
Therapeutic technique enhancement
Vital says learners will expand their skills and enhance therapeutic techniques. This suggests training in improving how they support clients in psychedelic-related therapeutic work.
3 roles · 0 guidelines · 1 courses · 1 providers
Tracking nervous systems and consent dynamics
The Colorado practicum site explicitly teaches relational competence, including tracking nervous systems, power, and consent dynamics moment by moment. This is presented as a core facilitation capability.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinHybrid in-person and virtual session support
The course teaches students to guide both in-person and online sessions, including the technical skills needed for virtual facilitation. It explicitly notes that online training includes learning tech skills to become a confident virtual guide.
3 roles · 0 guidelines · 0 courses · 1 providers
PsilocybinKetamineDMT / Ayahuasca+1 moreVirtual safety and support management
The program states that the virtual training has been streamlined so students feel safe and supported no matter what arises. This signals competency in maintaining safety in online psychedelic support contexts.
3 roles · 0 guidelines · 0 courses · 1 providers
General psychedelic-assisted practice skills
Catch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.
8 roles · 45 guidelines · 27 courses · 18 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 more
Other care stages
Follow the competency map across the care pathway.